Skip to evidence report

T.CD8_transitional: Studies

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

Subtype · 25,000 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 1–1,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for T.CD8_transitional
#Trait / studyIndividual trait IDMean IC score
1Psoriasis vulgaris (PheCode 696.41)GCST9047619056.62
2Allergic contact dermatitisFING0000006856.59
3Nasal polypFING0000085856.12
4Psoriatic arthritisGCST9024395654.68
5CXCL9 levelsGCST9046893554.29
6Psoriasis (PheCode 696.4)GCST9047618753.25
7Psoriasis and related disorder (PheCode 696)GCST9047618652.96
8TXNL1 levelsGCST9047099352.30
9FCRL6 levelsGCST9046920950.40
10Multiple sclerosisGCST9047583349.96
11Second line medication for Crohn's diseaseFING0000128449.67
12CXCL16 levelsGCST9046892847.97
13TNFRSF8 levelsGCST9047091547.48
14Chronic sinusitisFING0000029847.32
15MS-disease / Multiple SclerosisFING0000083946.84
16Lymphocyte countGCST9002598445.75
17CRTAM/VCAM1 ratioGCST9031428145.26
18GZMA/GZMH ratioGCST9031500844.91
19RBFOX3 levelsGCST9047043244.31
20PAFAH1B3 levelsGCST9047014544.24
21Lymphoid neoplasms (somatic mutation group 2 phenocluster)GCST9062475044.19
22Papulosquamous disordersFING0000114443.78
23PsoriasisGCST9001901643.45
24Lymphoid neoplasms (B-cell phenocluster)GCST9062473642.46
25Asthma-related infectionsFING0000011842.39
26IL15 levelsGCST9046955642.11
27Reimbursement for rheumatic diseasesFING0000124741.98
28Lymphocyte countGCST9001874241.97
29Type 1 diabetesGCST9000052941.79
30RPE levelsGCST9047049541.42
31CD48/CRTAM ratioGCST9031383941.19
32CD160/KLRB1 ratioGCST9031373141.07
33CD244/CRTAM ratioGCST9031376340.84
34Asthma | Chronic lower respiratory diseasesUKBB0000005340.77
35Asthma | respiratoryUKBB0000005440.61
36Atopic dermatitisFING0000012540.12
37Lymphocyte countGCST9000231740.08
38GNLY levelsGCST9046937239.75
39Type 1 diabetesGCST9001379139.57
40Rheumatoid arthritisFING0000126739.31
41Suggestive for eosinophilic asthmaFING0000134439.03
42NCR1 levelsGCST9047000938.64
43GZMH levelsGCST9046942538.58
44lymphocyte (absolute count, mean, inv-norm transformed)GCST9047542638.19
45lymphocyte (absolute count, maximum, inv-norm transformed)GCST9047542337.83
46Left-hemisphere dorsal attention network to amygdala white-matter structural connectivityGCST9030270637.59
47Thyroid peroxidase antibody positivity in pregnancyGCST9043520237.56
48CD5/TNFRSF9 ratioGCST9031386237.32
49Lymphoid neoplasmsGCST9062474337.29
50IDO1 levelsGCST9046950637.22
51IFNG levelsGCST9046951537.21
52Dermatitis and eczemaFING0000040237.13
53CD160/NCR1 ratioGCST9031373237.01
54CD160/CXCL16 ratioGCST9031372836.82
55GNLY/GZMA ratioGCST9031494936.76
56Autoimmune diseases excluding thyroid diseasesFING0000013236.74
57GZMA/GZMB ratioGCST9031500736.58
58Asthma-related acute respiratory infectionsFING0000011736.27
59Asthma/COPD (KELA code 203)FING0000012136.11
60AsthmaGCST9046811235.92
61CRTAM/FCRL6 ratioGCST9031427435.49
62Lymphoid neoplasms (drug group 1 phenocluster)GCST9062474035.41
63CCL17/PDGFB ratioGCST9031368835.26
64lymphocyte (absolute count, minimum, inv-norm transformed)GCST9047542935.23
65Pain type(s) experienced in last month - Pain all over the body | PainUKBB0000063235.23
66ITGAL levelsGCST9046963735.06
67CD8A levelsGCST9046865534.41
68Seropositive rheumatoid arthritis, wideFING0000129834.28
69Hypothyroidism | endocrine/metabolicUKBB0000033534.26
70LTA levelsGCST9046981334.12
71Non-cancer illness code, self-reported - hypothyroidism/myxoedema | Medical conditionsUKBB0000051833.97
72Other hypothyroidism | Disorders of thyroid glandUKBB0000061133.83
73Eosinophill count | Blood countUKBB0000020633.81
74Rheumatoid arthritisGCST9013222333.77
75eosinophil (absolute count, mean, inv-norm transformed)GCST9047529133.70
76HypothyroidismGCST9046813833.67
77Autoimmune diseasesFING0000013133.50
78PsoriasisFING0000122233.47
79HLAE/IL15 ratioGCST9031506133.25
80HypothyroidismGCST9020416733.04
81Lymphocyte count (UKB data field 30120)GCST9046808232.92
82Hypothyroidism NOS | endocrine/metabolicUKBB0000033632.91
83eosinophil (absolute count, maximum, inv-norm transformed)GCST9047528832.80
84Atopic dermatitisGCST9002716132.77
85Thyroid peroxidase antibody levels in pregnancyGCST9043520132.74
86AsthmaGCST01004232.61
87Asthma (childhood onset)GCST00780032.53
88PALM2 levelsGCST9047015232.42
89Prescriptions - levothyroxine | thyroid hormoneUKBB0000068732.31
90Prescriptions - thyroid hormone | hormoneUKBB0000070532.31
91Eosinophill percentage (UKB data field 30210)GCST9046806932.16
92Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Asthma | Medical conditionsUKBB0000009832.13
93HyperthyroidismGCST9046813632.09
94Eosinophil countGCST00460632.09
95Asthma (only as main-diagnosis) (more control exclusions)FING0000011432.01
96eosinophil (absolute count, minimum, inv-norm transformed)GCST9047529432.00
97Treatment/medication code - levothyroxine sodium | MedicationsUKBB0000084931.97
98Chronic lower respiratory diseasesFING0000029031.86
99Mouth/teeth dental problems - Mouth ulcers | MouthUKBB0000048831.85
100Seropositive rheumatoid arthritis, strict definitionFING0000129731.84
101Lymphocyte countGCST9000231631.77
102Lymphocyte countGCST9000238831.75
103eosinophil (fraction, maximum, inv-norm transformed)GCST9047529731.70
104Psoriasis vulgarisFING0000122431.63
105Lymphocyte count | Blood countUKBB0000041131.56
106CXCL10 levelsGCST9046892330.98
107Neutrophil percentage of granulocytesGCST00462330.97
108Other diseases of upper respiratory tractFING0000101230.89
109Prescriptions - tramadol | opioid analgesic,selective serotonin re-uptake inhibitor,norepinephrine re-uptake inhibitorUKBB0000070630.85
110Prescriptions - opioid analgesic|selective serotonin re-uptake inhibitor|norepinephrine re-uptake inhibitorUKBB0000069430.85
111Asthma (adult onset)GCST00779930.80
112eosinophil (fraction, minimum, inv-norm transformed)GCST9047530330.75
113Rheumatoid arthritisGCST9013222430.51
114Eosinophil percentage of granulocytesGCST00461730.41
115IL18 levelsGCST9042841130.35
116Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - None of the above | Medical conditionsUKBB0000010130.24
117Eosinophill percentage | Blood countUKBB0000020730.23
118Allergy/adverse effect of penicillin | injuries & poisoningsUKBB0000002830.20
119Diseases of hair and hair follicles (PheCode 704)GCST9047620930.16
120Sum eosinophil basophil countsGCST00462430.14
121Treatment or medication use - levothyroxine sodium (UKB data field 20003_1141191044)GCST9004253529.96
122Graves disease, strict definitionFING0000059229.90
123Hypothyroidism NOS (PheCode 244.4)GCST9047565329.75
124Respiratory disease (confirmatory factor analysis Factor 11)GCST9030934529.70
125Eosinophil percentage of white cellsGCST00460029.68
126Lymphocyte countGCST00462729.68
127SNRPB2 levelsGCST9047069729.58
128Rash and other nonspecific skin eruption (PheCode 687.1)GCST9047616729.57
129Disorders of the thyroid glandFING0000046329.42
130Pulmonary fibrosisGCST9001868829.40
131First line medication for Crohn's diseaseFING0000054429.35
132Thyroid problemsGCST9047527629.34
133Non-cancer illness code, self-reported - asthma | Medical conditionsUKBB0000050629.06
134Personal history of allergy to drugs, medicaments and biologocal substances | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB0000064129.04
135Disorders of orbitFING0000044928.90
136GZMB/IL15 ratioGCST9031501528.82
137Chronic dermatitis due to solar radiation (PheCode 938.2)GCST9047628828.78
138eosinophil (fraction, mean, inv-norm transformed)GCST9047530028.68
139Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Hayfever, allergic rhinitis or eczema | Medical conditionsUKBB0000010028.64
140LAT/LYN ratioGCST9031528328.48
141PsoriasisGCST9046814728.37
142Hypothyroidism (PheCode 244)GCST9047564728.28
143Hypothyroidism, strict autoimmuneFING0000065628.27
144Type 1 diabetesGCST9001402328.27
145AsthmaGCST9001432528.23
146HSIL lesion of the cervix uteriFING0000062428.18
147Eosinophil percentage of white cellsGCST9000238228.16
148CD5 levelsGCST9046864127.98
149S100A11/S100A12 ratioGCST9031579827.95
150KDM3A levelsGCST9046967127.81
151Takes medication for Thyroid problems?GCST9047527727.76
152Seborrhoeic dermatitisFING0000128227.68
153lymphocyte (fraction, maximum, inv-norm transformed)GCST9047543227.56
154TNFRSF17 levelsGCST9047090827.47
155APRT levelsGCST9046834527.46
156Asthma (more control exclusions)FING0000011327.40
157CD160 levelsGCST9046859927.25
158Noninfective enteritis and colitisFING0000088127.25
159Thyroid peroxidase antibody positivity with euthyroid in pregnancyGCST9043520327.24
160CRTAM levelsGCST9046887127.15
161GZMA/LTA ratioGCST9031501227.12
162mean corpuscular hemoglobin (MCH, mean, inv-norm transformed)GCST9047544427.08
163Eosinophil countGCST9000229827.05
164Basal cell carcinoma (MTAG)GCST9013741127.01
165Lichen ruber planus, wide definition including periferal and oral lichen planusFING0000072227.00
166Eosinophill count (UKB data field 30150)GCST9046806826.94
167Eosinophil countGCST9000238126.85
168SarcoidosisGCST9050348326.79
169CRTAM/LY9 ratioGCST9031427826.76
170HypothyroidismGCST9031932026.71
171Systemic lupus erythematosusGCST9001186626.32
172Childhood asthma (age<16) (more control exclusions)FING0000027026.21
173ACYP1 levelsGCST9046821426.17
174GZMA/TNFRSF8 ratioGCST9031501426.02
175CD8 on Effector Memory CD8+ T cellGCST9000205625.88
176Blood cell traits latent factor 3 (white cell)GCST9055924525.87
177IL2RB levelsGCST9046958625.83
178Mosaic chromosomal alteration of the X chromosomeGCST9016528725.83
179CD48/FCRL6 ratioGCST9031384025.73
180GZMB levelsGCST9046942425.70
181Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)FING0000075625.43
182Type1 diabetes, definitions combined, early onsetFING0000138425.40
183GZMH/KLRD1 ratioGCST9031501625.31
184Allergic disease (asthma, hay fever or eczema)GCST00503825.30
185Ulcerative rectosigmoiditisFING0000139425.29
186SKAP1 levelsGCST9047064525.19
187NBN levelsGCST9047000225.08
188MZB1 levelsGCST9046998725.04
189IL15/IL18BP ratioGCST9031514824.92
190Seronegative rheumatoid arthritisFING0000129624.91
191Chronic lymphocytic leukemiaGCST9062473824.83
192Nasal polyps | respiratoryUKBB0000049424.62
193BOLA2 or BOLA2B levelsGCST9046846024.60
194Neurofibromatosis, type 2FING0000086724.58
195Poisoning by antibiotics | injuries & poisoningsUKBB0000065324.56
196Asthma and allergyFING0000011524.49
197DNAJC21 levelsGCST9046901624.47
198GZMA/TNFRSF4 ratioGCST9031501324.27
199lymphocyte (fraction, mean, inv-norm transformed)GCST9047543524.22
200Other demyelinating diseases of the central nervous systemFING0000099524.19
201CRTAM/GZMA ratioGCST9031427524.15
202CD244/FCRL6 ratioGCST9031376523.99
203CD79B/TNFRSF4 ratioGCST9031390323.95
204Wheeze or whistling in the chest in last year (UKB data field 2316)GCST9004361423.91
205Seborrheic dermatitis (PheCode 690.1)GCST9047617123.90
206CRTAM/ICAM3 ratioGCST9031427623.90
207Primary biliary cholangitis (PBC)FING0000121123.88
208Blood cell traits latent factor 9 (white cell)GCST9055925123.86
209Wheeze or whistling in the chest in last year | BreathingUKBB0000091223.83
210ThyrotoxicosisFING0000136023.80
211Coeliac diseaseGCST9046812023.79
212Allergic asthma (mode)FING0000006623.69
213Erythematosquamous dermatosis (PheCode 690)GCST9047617023.65
214SMNDC1 levelsGCST9047068123.50
215Lymphocyte percentage | Blood countUKBB0000041223.46
216DTI autoptx MD cgc l tractGCST9038522423.44
217Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complicationsGCST9009311323.44
218Ceramide (d18:2/22:0) levelsGCST9002468223.38
219KLRB1 levelsGCST9046970923.38
220Inflammatory bowel disease, strict (require KELA)FING0000067523.32
221Lymphocyte percentage of white cellsGCST9000238923.31
222Principal component-derived dietary pattern 26GCST9013303123.31
223CD6 levelsGCST9046864423.28
224PolyarthropathiesFING0000118023.23
225Lymphocyte percentage (UKB data field 30180)GCST9046808323.22
226IPCEF1/SERPINE1 ratioGCST9031518423.14
227IridocyclitisFING0000069623.07
228Cerebrospinal fluid methylmalonate (MMA) levelsGCST9031824323.05
229LHPP levelsGCST9046976823.04
230Other/unspecified rheumatoid arthritisFING0000112622.97
231GBP1 levelsGCST9046931122.86
232Non-cancer illness code, self-reported - eczema/dermatitis | Medical conditionsUKBB0000050922.86
233FCRL6/GZMA ratioGCST9031480622.85
234COPD/asthma/ILD related infectionsFING0000035322.83
235Omega-3 fatty acids to Omega-6 fatty acids ratioGCST9050239622.79
236Non-cancer illness code, self-reported - hayfever/allergic rhinitis | Medical conditionsUKBB0000051322.76
237IL15/NCR1 ratioGCST9031515022.71
238CRTAM/TNFRSF9 ratioGCST9031428022.67
239Ulcerative colitisGCST9001871322.62
240Smoking status (weighted GWA)GCST9026730322.57
241ICD10 N87: Dysplasia of cervix uteriGCST9045421822.56
242BLNK levelsGCST9046844822.53
243HSIL lesion of the cervix uteri, vagina or vulvaFING0000062522.53
244PDCD1 levelsGCST9047018122.47
245Crohn disease (strict definition, require KELA, min 2 HDR)FING0000036622.42
246CD7 levelsGCST9046864922.29
247DKK1/IPCEF1 ratioGCST9031447122.28
248PCBD1 levelsGCST9047016622.20
249Asthma with exacerbation (PheCode 495.2)GCST9047602522.17
250Thyrotoxicosis with diffuse goitreFING0000136122.14
251Other (seronegative) rheumatoid arthritis, wideFING0000091722.09
252Nasal polyp | Other diseases of upper respiratory tractUKBB0000049322.09
253Neutrophils and lymphocytes in blood (confirmatory factor analysis Factor 35)GCST9030936922.05
254PPM1B levelsGCST9047029622.04
255Acute upper respiratory infectionsFING0000003422.03
256CWC15 levelsGCST9046892021.89
257Graves' disease (PheCode 242.1)GCST9047564421.86
258Rheumatoid arthritisGCST9001869021.82
259Eosinophil countGCST9000229921.82
260Rosacea (PheCode 695.3)GCST9047617821.76
261CLC levelsGCST9046876221.75
262Lymphoid leukemia, chronic (PheCode 204.12)GCST9047561321.72
263lymphocyte (fraction, minimum, inv-norm transformed)GCST9047543821.66
264OSMR levelsGCST9047013221.62
265T1 FreeSurfer aseg MaskVol-to-eTIVGCST9038419221.54
266Plasma ascorbic acid 2-sulfate levels in chronic kidney diseaseGCST9026483221.38
267BMP7 levelsGCST9008815721.31
268Overweight, obesity and other hyperalimentation | endocrine/metabolicUKBB0000062221.22
269Primary biliary cholangitisGCST9006144021.13
270Omega-3 fatty acids to total fatty acids percentageGCST9050246021.07
271SMPD3 levelsGCST9047068521.01
272Disorders of sclera, cornea, iris and ciliary bodyFING0000045821.01
273DTI TBSS MD Superior corona radiata LGCST9038459720.98
274ARHGAP30 levelsGCST9046835420.92
275Eosinophil countGCST9001873320.92
276VEGFB levelsGCST9047103520.91
277LTA4H levelsGCST9046981220.67
278Idiopathic pulmonary fibrosisFING0000065920.46
279CXCL16/NOTCH1 ratioGCST9031433920.46
280Volume of right central nucleusGCST9047491620.41
281Coeliac diseaseFING0000031220.37
282Benign leiomyoma with endometriosis (controls excluding all cancers)FING0000014520.35
283TALDO1 levelsGCST9047080220.33
284DNA methylation-estimated granulocyte proportionsGCST9001428720.33
285Type 1 diabetes, definitions combinedFING0000138020.28
286Blood cell traits latent factor 17 (white cell)GCST9055925920.18
287Inflammatory bowel disease and other gasteroenteritis and colitis (PheCode 555)GCST9047606520.14
288Sporadic miscarriageGCST01188820.05
289Avoided activities or situations because of previous stressful experience in past month | Traumatic eventsUKBB0000008320.04
290Other and unspecified tonsillitisFING0000095420.03
291Inflammatory bowel diseaseGCST9043218220.00
292ICD10 O60: Preterm labor and deliveryGCST9045424219.98
293MAPRE3 levelsGCST9046985919.90
294CD101 levelsGCST9046859619.85
295Hypothyroidism, drug reimbursementFING0000065519.73
296IL5RA/TNFRSF13B ratioGCST9031516419.71
297EDAR/EGF ratioGCST9031457319.64
298Rheumatoid arthritis (PheCode 714.1)GCST9047623019.57
299Operation code - tonsillectomy +/- adenoids | OperationsUKBB0000056719.47
300KIR3DL1 levelsGCST9046968719.46
301HayfeverGCST9046813119.36
302FCRL6/KLRD1 ratioGCST9031480719.24
303Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)GCST9013222719.13
304aseg lh volume HippocampusGCST9000262419.11
305C5 levelsGCST9046850019.04
306Colitis, primary sclerosing, strict definitionFING0000031319.02
307Other acute lower respiratory infectionsFING0000092118.97
308Basal cell carcinoma (PheCode 172.21)GCST9047558218.97
309IFI30 levelsGCST9046950918.90
310FASLG levelsGCST9046919118.79
311Non-cancer illness code, self-reported - hiatus hernia | Medical conditionsUKBB0000051518.75
312mean corpuscular hemoglobin (MCH, minimum, inv-norm transformed)GCST9047544818.70
313Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80)GCST9066852418.68
314X-21285 levelsGCST9020057618.61
315RILP levelsGCST9047047118.52
316DTI TBSS MD Posterior limb of internal capsule LGCST9038459118.44
317T1 FreeSurfer DK rh supramarginal volumeGCST9038578718.40
318Obesity | endocrine/metabolicUKBB0000054418.38
319FCRL5/LY96 ratioGCST9031480318.35
320Obesity | Obesity and other hyperalimentationUKBB0000054518.18
321Skin cancerGCST9047557518.14
322Nasal polyps (PheCode 471)GCST9047601918.14
323CD300A levelsGCST9046861918.13
324Juvenile rheumatoid arthirtisFING0000070618.13
325AsthmaGCST9047525918.05
326Omega-3 fatty acids to total fatty acids percentageGCST9050244818.05
327CD48/SLAMF7 ratioGCST9031384218.01
328PDCD1/TNFRSF8 ratioGCST9031561018.01
329CRTAM/PDCD1 ratioGCST9031427917.97
330Nonspecific chest pain | circulatory systemUKBB0000052717.97
331IL2RA/NCR1 ratioGCST9031516117.89
332TNFRSF19 levelsGCST9008894717.89
333Ceramide (d18:2/22:0) levelsGCST9002405417.85
334Eosinophil countGCST9002598717.83
335Graves' diseaseGCST9001862717.80
336ICD10 N84: Polyp of female genital tractGCST9045421617.79
337Atopic/contact dermatitis due to other or unspecified (PheCode 939)GCST9047628917.76
3383-methyl-2-oxobutyrate levelsGCST9019967717.72
339APBB1IP/POLR2F ratioGCST9031330017.54
340Ulcerative colitisGCST00413317.53
341Medication use (drugs affecting bone structure and mineralization)GCST9001877317.52
342Autoimmune hyperthyroidismFING0000013417.42
343SIT1 levelsGCST9047064417.41
344Acute pancreatitisFING0000002717.33
345Treatment/medication code - ibuprofen | MedicationsUKBB0000084717.30
346CRTAM/KLRD1 ratioGCST9031427717.28
347Left-hemisphere control network to amygdala white-matter structural connectivityGCST9030275717.25
348Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classifiedFING0000043217.12
349PDCD5 levelsGCST9047018217.11
350KLF4 levelsGCST9046969417.11
351Multiple myeloma or monoclonal gammopathy of undetermined significanceGCST9062474616.98
352Other non-epithelial cancer of skin (PheCode 172.2)GCST9047558016.97
353T1 FreeSurfer BA lh V2 exvivo thicknessGCST9038552916.96
354Alcohol-induced chronic pancreatitisFING0000005516.96
355TBCA levelsGCST9047081216.87
356Monoclonal gammopathy of undetermined significanceGCST9062474516.85
357DNA methylation PhenoAge accelerationGCST9001429216.84
358Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)FING0000076416.83
359SELPLG levelsGCST9047056816.83
360Eosinophil count varianceGCST9056568916.75
361Diseases of white blood cells (PheCode 288)GCST9047581216.73
362PTPRC levelsGCST9047038016.72
363PAG1 levelsGCST9047014716.69
364KLRF1 levelsGCST9046971216.67
365Primary biliary cholangitisGCST00312916.62
366KIR2DL3 levelsGCST9046968516.61
367CCL17/CD69 ratioGCST9031368416.57
368Lung cancerGCST9001865516.56
369PollinosisGCST9001868316.55
370Melanomas of skin (PheCode 172.11)GCST9047557816.53
371PAXX levelsGCST9047016116.52
372EGFL7 levelsGCST9046908316.49
373CD27/NBL1 ratioGCST9031377416.47
374DTI autoptx L1 cst l tractGCST9038514716.47
375Rheumatoid arthritisGCST00067916.46
376CD244 levelsGCST9046861116.46
377HyperthyroidismGCST9031931916.42
378Other specified disorders of external earFING0000110416.39
379SH2B3/TBL1X ratioGCST9031584116.39
380IL5RA levelsGCST9046960016.37
381SRP14 levelsGCST9047074216.33
382INSR levelsGCST9046962316.33
383DTI autoptx MD str r tractGCST9038524416.32
384Lymphocyte percentage of white cellsGCST00463216.32
385TNFSF12 levelsGCST9027484616.32
386Prescriptions - antispasmodicUKBB0000066616.31
387ROR1/THBD ratioGCST9031578616.30
388EczemaGCST9046812616.27
389Sicca syndrome [Sjögren]FING0000130416.20
390ChalazionFING0000026716.17
391aparc-a2009s rh thickness G-temporal-middleGCST9000371416.16
392Skin color (cheek, ITA value)GCST9050278016.14
393Fluid intelligence score decline (difference score)GCST9056586216.12
394BCL2 levelsGCST9046843316.10
395LCN2/S100A12 ratioGCST9031530916.09
396CD5/IL16 ratioGCST9031386116.07
397Multiple myelomaGCST9062474716.01
398PM: initial answer - Orange circle| Prospective memoryUKBB0000065215.96
399Mean corpuscular hemoglobin concentrationGCST9001874515.96
400CCL19 levelsGCST9046857115.96
401Lymphoid neoplasms (P-cell phenocluster)GCST9062473715.87
402Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80)GCST9066875815.86
403Ulcerative colitis (PheCode 555.2)GCST9004415515.84
404CD27/TGFBR2 ratioGCST9031377615.79
405SH2D1A levelsGCST9047061715.76
406WARS levelsGCST9047106615.74
407T1 FreeSurfer DKT rh supramarginal volumeGCST9038437715.70
408GZMA levelsGCST9046942315.67
409CLEC1B/DAB2 ratioGCST9031408615.59
410CRTAP levelsGCST9046887215.58
411EndometriosisGCST9001861915.57
412HSPB1 levelsGCST9017931715.56
413GRAP2/SRC ratioGCST9031498915.56
414SarcoidosisFING0000127515.56
415TRAF2/WWP2 ratioGCST9031594315.52
416MAVS/TBL1X ratioGCST9031539915.42
417PIKFYVE levelsGCST9047023515.38
418Interpolated Year when non-cancer illness first diagnosed | Medical conditionsUKBB0000037115.38
419Treatment/medication code - ventolin 100micrograms inhaler | MedicationsUKBB0000086015.34
420HippSubfield lh volume Hippocampal-tailGCST9000266815.28
421Hair colour (natural, before greying): Dark brown (UKB data field 1747_4)GCST9004183915.28
422DNAJB2 levelsGCST9046901315.25
423DTI TBSS L3 Genu of corpus callosumGCST9038452615.24
424KLRK1 levelsGCST9046971315.24
425Hair colour (natural, before greying) - Dark brown | Sun exposureUKBB0000029715.22
426HippSubfield lh volume GC-ML-DG-headGCST9000267915.19
427Early-onset myasthenia gravisGCST9009346515.11
428MelanomaGCST9001180915.09
429DCTN1/TRIAP1 ratioGCST9031443415.07
430Bipolar disorderGCST00372415.03
431CXCL11/DKK1 ratioGCST9031433415.00
432Squamous cell carcinoma (PheCode 172.22)GCST9047558314.96
433PBLD levelsGCST9047016314.94
434Preterm labour and deliveryFING0000120914.94
435Crohn's disease NASFING0000036714.91
436AHSP/HMBS ratioGCST9031321714.88
437Asthma-related pneumoniaFING0000011914.88
438Melanomas of skin, dx or hx (PheCode 172.1)GCST9047557714.82
439CD40LG/TRAF2 ratioGCST9031382814.82
440Urine N-acetylglutamate levels in chronic kidney diseaseGCST9026556914.82
441LCN2/PGLYRP1 ratioGCST9031530614.78
442ConjunctivitisFING0000034614.72
443DTI TBSS L3 Sagittal stratum LGCST9038455514.70
444Mean reticulocyte volumeGCST9002597514.68
445Basophil countGCST9000229314.66
446STX6 levelsGCST9047077414.66
447Treatment speciality of consultant (recoded) - Trauma & orthopaedics | Summary AdministrationUKBB0000083714.64
448Blood cell traits latent factor 12 (red cell)GCST9055925414.64
449AsthmaGCST00686214.63
450Mean corpuscular hemoglobin concentrationGCST9000232914.61
451Ulcerative colitis (strict definition, require KELA, min 2 HDR)FING0000138814.50
452HSPA1A levelsGCST9046948714.49
453Non-albumin protein levelsUKBB0000050314.47
454UGDH levelsGCST9047100614.44
455Percentage of monosialylation of core-fucosylated monogalactosylated structures without bisecting GlcNAc (GP41)GCST9066848514.41
456GLO1 levelsGCST9046935814.40
457Solitary pulmonary nodule (PheCode 514.2)GCST9047604414.37
458Incidence of bisecting GlcNAc in all fucosylated disialylated structures (GP57)GCST9066873514.36
459Mean reticulocyte volume | Blood countUKBB0000045114.34
460Percentage of fucosylation of monogalactosylated structures in total neutral plasma glycans (GP74)GCST9066851814.31
461Internal derangement of knee (PheCode 835)GCST9047628214.30
462HippSubfield lh volume Whole-hippocampusGCST9000268914.30
463CD27/DLL1 ratioGCST9031377114.28
464APRT/CD63 ratioGCST9031333414.24
465AHNAK levelsGCST9046826114.22
466BOC levelsGCST9046845814.19
467IL15/KLRD1 ratioGCST9031514914.12
468TP53I3 levelsGCST9047093714.07
469Ever SmokerFING0000052213.98
470AKT1S1/FHIT ratioGCST9031322813.95
471Infective dermatitisFING0000067313.93
472MICB or MICA levelsGCST9046990513.93
473Plasma taurocholenate sulfate* levels in chronic kidney diseaseGCST9026604013.92
474aparc-Desikan rh volume insulaGCST9000283413.91
475Skin cancerGCST9047518913.89
476FCRL5/ICAM3 ratioGCST9031480213.87
477PDCD1/TNFRSF4 ratioGCST9031560913.82
478Blood cell traits latent factor 20 (red cell)GCST9055926213.74
479Other non-epithelial cancer of skin | neoplasmsUKBB0000061513.71
480SPINK2 levelsGCST9047072213.67
481MICB_MICA/TEK ratioGCST9031544613.64
482ENO3 levelsGCST9046911113.61
483HippSubfield lh volume CA4-bodyGCST9000268313.60
484AsthmaGCST9047602413.58
485Regional enteritis (PheCode 555.1)GCST9047606613.58
486IL10 levelsGCST9046954613.55
487TIGIT levelsGCST9047086513.54
488Peripheral or central vertigo (PheCode 386.2)GCST9047590713.53
489ZNF830 levelsGCST9047110213.52
490ARHGAP25/RNF41 ratioGCST9031334513.49
491Cervical cancerGCST9001181613.47
492Principal component-derived dietary pattern 9GCST9013301413.47
493Mouth/teeth dental problems - None of the above | MouthUKBB0000048913.47
494CDH17/PTPRM ratioGCST9031394313.46
495EDAR/F2R ratioGCST9031457713.44
496Attendance/disability/mobility allowance - None of the above | Other sociodemographic factorsUKBB0000005913.43
497STIP1 levelsGCST9047076413.42
498Dissociative [conversion] disordersFING0000046813.40
499Lichen simplex chronicus and prurigoFING0000072513.37
500ALB/Globulin ratioUKBB0000002013.33
501Basal cell carcinomaGCST9001341013.33
502FOXO3 levelsGCST9046926613.29
503HippSubfield lh volume GC-ML-DG-bodyGCST9000268113.29
504MAVS/MED18 ratioGCST9031538913.24
505FUT8/RSPO1 ratioGCST9031489113.21
506Rheumatoid arthritis | musculoskeletalUKBB0000075713.18
507JCHAIN levelsGCST9046966113.17
508Age hay fever, rhinitis or eczema diagnosed | Medical conditionsUKBB0000001513.11
509MSRA/PRDX5 ratioGCST9031549713.11
510Mean sphered cell volume (UKB data field 30270)GCST9046808913.08
511CD27/NECTIN4 ratioGCST9031377513.08
512mean corpuscular volume (MCV, minimum, inv-norm transformed)GCST9047547413.04
513LAIR2 levelsGCST9046972913.03
514Celiac disease (PheCode 557.1)GCST9004415813.03
515Systemic connective tissue disordersFING0000135013.00
516PEAR1/PECAM1 ratioGCST9031564112.98
517Psoriatic arthropathiesFING0000122512.95
518CCR2 on CD14+ CD16- monocyteGCST9000200412.94
519MZB1/TNFRSF13B ratioGCST9031550912.94
520MAN2B2 levelsGCST9046984412.92
521Rheumatoid arthritis and other inflammatory polyarthropathies | musculoskeletalUKBB0000075812.90
522NAP1L4 levelsGCST9046999812.89
523Belief that own life is meaningful | Happiness and subjective well-beingUKBB0000009012.85
524Crohn's diseaseGCST9044679312.85
525Handedness (chirality/laterality) - Left-handed | Early life factorsUKBB0000030212.85
526ELOA/POLR2F ratioGCST9031464312.84
527SH3GLB2 levelsGCST9047062112.83
528Number of attempts | Prospective memoryUKBB0000053112.83
529Other malignant neoplasms of skin | Melanoma and other malignant neoplasms of skinUKBB0000061312.83
530Crohn's disease of small intestineFING0000036912.82
531mean corpuscular volume (MCV, mean, inv-norm transformed)GCST9047547012.80
532Eosinophil percentage of white cells varianceGCST9056569012.78
533RIDA levelsGCST9047046912.73
534S100A12 levelsGCST9047051312.73
535DTYMK levelsGCST9046904912.71
536Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)FING0000077212.69
537Lumbar disc prolapseFING0000073512.69
538Educational attainmentGCST00259812.67
539ENO2/RWDD1 ratioGCST9031466712.58
540CD20 on IgD- CD27- B cellGCST9000175412.56
541Crohn's diseaseGCST00413212.54
542CC2D1A/STAMBP ratioGCST9031366412.53
543IGLC2 levelsGCST9046953612.51
544Paraproteinemia (PheCode 270.32)GCST9047571012.51
545aparc-a2009s rh thickness G-oc-temp-med-LingualGCST9000369812.47
546Neoplasm of uncertain behavior of skin (PheCode 173)GCST9047558512.47
547Methods of admission to hospital (recoded) - Elective admission: Booked | Summary AdministrationUKBB0000046112.46
548CXCL16 levelsGCST9024052412.45
549Actinic keratosis (PheCode 702.1)GCST9047620412.44
550Obesity related asthmaFING0000089712.40
551Chronic hepatitis B infectionGCST9001858412.38
552mean corpuscular volume (MCV, maximum, inv-norm transformed)GCST9047546612.37
553Rhodanobacter abundance in stoolGCST9003253612.36
554CDH17/PECAM1 ratioGCST9031394212.33
555EDAR/TACC3 ratioGCST9031458912.30
556DTI TBSS MD Genu of corpus callosumGCST9038457412.26
557ST13 levelsGCST9047075112.24
558KCTD5 levelsGCST9046967012.23
559Pain in throat and chest | Symptoms and signs involving the circulatory and respiratory systemsUKBB0000062512.22
560Hair colour (natural, before greying) - Black | Sun exposureUKBB0000029512.17
561Lung adenocarcinomaGCST00474412.13
562Chromatiales abundance in stoolGCST9003231812.06
563Types of physical activity in last 4 weeks - None of the above | Physical activityUKBB0000087212.04
564Hair colour (natural, before greying): Red (UKB data field 1747_2)GCST9004183712.03
565Endometrial cancerGCST00646412.03
566PFKM levelsGCST9061880212.02
567GP6/HPCAL1 ratioGCST9031496312.01
568Ratio of bis-allylic bonds to double bonds in lipidsGCST9013274412.00
569Symptoms involving digestive system (PheCode 561)GCST9047606911.98
570FUT8/TNFSF14 ratioGCST9031489511.98
571Biological Sibling: AsthmaGCST9047637211.97
572Vanillactate levelsGCST9019997811.97
573T1 FreeSurfer a2009s lh S postcentral areaGCST9038473411.95
5745-oxoproline levelsGCST9024343711.95
575Acute bronchitisFING0000002111.95
576Epstein-Barr virus ZEBRA antibody levelsGCST9000690111.94
577PM: initial answer - Blue square | Prospective memoryUKBB0000065111.93
578Principal component-derived dietary pattern 12GCST9013301711.88
579mean corpuscular hemoglobin (MCH, minimum, inv-norm transformed)GCST9047545011.86
580Current SmokerFING0000037111.84
581CA1/HMBS ratioGCST9031357311.84
582GOPC/IRAK4 ratioGCST9031495411.75
583CSNK1D levelsGCST9046888811.75
584Mean sphered cell volume | Blood countUKBB0000045211.71
585CDA levelsGCST9046866011.70
586White blood cell countGCST9002598511.69
587HippSubfield lh volume CA4-headGCST9000268211.66
588Ulcerative colitisGCST9044679511.65
589Acute renal failureFING0000003011.65
590DTI TBSS L3 Superior corona radiata LGCST9038454911.64
591CA3/HMBS ratioGCST9031358411.59
592Omega-3 fatty acids to total fatty acids percentageGCST9050208711.56
593CD27/TNFRSF9 ratioGCST9031377811.55
594MAP2K1 levelsGCST9046985111.55
595mean corpuscular hemoglobin (MCH, maximum, inv-norm transformed)GCST9047544211.55
596HLA-A levelsGCST9046945711.53
597CD27 levelsGCST9046861511.52
598neutrophil (fraction, minimum, inv-norm transformed)GCST9047554111.51
599Pilonidal cystFING0000116711.50
600KIR2DL2 levelsGCST9046968411.48
601F2R/SNX9 ratioGCST9031473611.47
602ICD10 N97.8: Female infertility of other originGCST9045422511.43
603DTI autoptx L1 cst r tractGCST9038514811.41
604Basophil countGCST9001872611.39
605Type 1 diabetesGCST9043206611.39
606CD48 levelsGCST9046863511.38
607LAYN/PTPRN2 ratioGCST9031529011.38
608FCRL5 levelsGCST9046920811.37
609GRHPR levelsGCST9046940011.37
610Ulcerative colitisGCST9047532211.30
611LSP1 levelsGCST9046981111.30
612CLEC4D/CLEC6A ratioGCST9031410911.30
613LBR/LGALS8 ratioGCST9031529411.26
614mean corpuscular hemoglobin (MCH, mean, inv-norm transformed)GCST9047544611.23
615EDAR/ERBIN ratioGCST9031457511.23
616CLPS/PLA2G1B ratioGCST9031414011.21
617Triacylglycerol_52:5_[M+NH4]1+ levelsGCST9006050611.12
618T1 FreeSurfer aseg Right-PallidumGCST9038416411.09
619PEBP1 levelsGCST9047020511.09
620AK1 levelsGCST9046826911.07
621Degenerative skin conditions and other dermatoses (PheCode 702)GCST9047620211.06
622HMBS/PKLR ratioGCST9031506311.03
623Doctor diagnosed hayfever or allergic rhinitis | Medical informationUKBB0000019211.02
624DEFA1_DEFA1B/PTGDS ratioGCST9031445511.01
625UrticariaFING0000140811.00
626CD27/CD79B ratioGCST9031377011.00
627Vitamin B12 deficiency anaemiaFING0000144110.99
628CEP85 levelsGCST9046871610.97
629DermatitisFING0000040110.96
630PSAPL1 levelsGCST9024235410.95
631Ulcerative colitis, NASFING0000139010.93
632Diseases of the digestive systemFING0000042910.92
633LBR/POLR2F ratioGCST9031529710.91
634BTN3A2 levelsGCST9046848110.89
635neutrophil (fraction, mean, inv-norm transformed)GCST9047553810.89
636CD6/EZR ratioGCST9031389010.87
637Human herpes virus 7 U14 antibody levelsGCST9000690910.86
638Scar conditions and fibrosis of skin (PheCode 701.2)GCST9047619810.85
639Neutrophil percentage of white cellsGCST9000239910.83
640DTI TBSS MD Superior longitudinal fasciculus LGCST9038461310.83
641Volume of right basal nucleusGCST9047501510.83
642IL1RL1 levelsGCST9046957410.81
643IPCEF1/SPARC ratioGCST9031518610.81
644Mean reticulocyte volumeGCST9000239610.76
645Bread type: Wholemeal/wholegrain vs white and brown (UKB data field 1448)GCST9013296810.75
646Omega-3 fatty acids to Omega-6 fatty acids ratioGCST9050207410.72
647TRAF3 levelsGCST9047095710.72
648Neutrophill percentage (UKB data field 30200)GCST9046809310.71
649Mean reticulocyte volume (UKB data field 30260)GCST9046808810.70
650Hernia abdominopelvic cavityGCST9008608710.66
651Volume of left anterior amygdaloid areaGCST9047493710.65
652CD300E/EFNA4 ratioGCST9031379710.64
653Back pain (PheCode 760)GCST9047626610.63
654Omega-3 fatty acid levelsGCST9050242210.62
655Frequency of stair climbing in last 4 weeks | Physical activityUKBB0000026610.61
656THBS2 levelsGCST9047085410.61
657SLITRK2 levelsGCST9047067010.61
658T1 FreeSurfer DK lh lingual thicknessGCST9038563410.60
659Skin cancer | neoplasmsUKBB0000077210.58
660IDP dMRI TBSS OD Posterior limb of internal capsule LGCST9000442110.58
661MVK/SERPINE1 ratioGCST9031550510.58
662DTI TBSS MD Cingulum cingulate gyrus LGCST9038460710.57
663Sjögren's syndromeGCST9001870010.54
664Orotidine levelsGCST9020068110.54
665CD74/NPDC1 ratioGCST9031389510.49
666Right-hemisphere dorsal attention network to amygdala white-matter structural connectivityGCST9030281110.49
667PRG3 levelsGCST9047032310.49
668Prospective memory result | Prospective memoryUKBB0000071310.48
669Psoriasis (vulgaris), strict definitionFING0000122310.47
670ATOX1/SNAP29 ratioGCST9031337410.47
671SUMF1 levelsGCST9047078310.44
672GRAP2/MAP4K5 ratioGCST9031498210.43
673Oxalate (ethanedioate) levelsGCST9019967210.40
674TSC1 levelsGCST9047097210.39
675Carboplatin drug response (IC50)GCST9001178310.37
676EZR levelsGCST9046916210.36
677IL16 levelsGCST9046955710.35
678HBEGF/PLXNA4 ratioGCST9031503610.34
679Time spent watching television (TV) | Physical activityUKBB0000082110.32
680CDH17/SPINT1 ratioGCST9031394410.29
681Biological Mother: High blood pressureGCST9047549010.28
682Tryptophan betaine levelsGCST9019981910.28
683HBEGF/WWP2 ratioGCST9031503810.28
684IGBP1 levelsGCST9046952110.28
685Volume of left central nucleusGCST9047488310.27
686ADAM15 levelsGCST9046821710.26
687CCS levelsGCST9046859410.24
688Trouble falling asleep when you first go to bedGCST9047638510.24
689HippSubfield lh volume Whole-hippocampal-bodyGCST9000268710.23
690YOD1 levelsGCST9047109010.22
691AXIN1/MAVS ratioGCST9031341410.22
692Mean corpuscular hemoglobinGCST9000239010.21
693Allergic conjunctivitisFING0000006710.21
694Mean spheric corpuscular volumeGCST9000239710.19
695Basophil countGCST9002599710.16
696FOXO1/USP8 ratioGCST9031487910.13
697IL32 levelsGCST9046959110.13
698BCR/FOXO1 ratioGCST9031349010.12
699UBXN1 levelsGCST9047100410.09
700T1 FreeSurfer BA lh BA2 exvivo volumeGCST9038553410.07
701TPSAB1 levelsGCST9047095110.04
702UCMA levelsGCST9024328510.02
703LYN/SIRT2 ratioGCST9031534910.02
704F-caffeinated/sweet liking (derived food-liking factor)GCST9009472010.01
705Neutrophill percentage | Blood countUKBB0000049810.01
706Takes medication for Skin condition (ex. Eczema, Psoriasis)?GCST9047527510.00
707T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 101)GCST903209209.99
708CLIC5 levelsGCST904217409.98
709DTI autoptx L3 slf r tractGCST903852159.98
710COX5B/GFER ratioGCST903142009.98
711CAPG levelsGCST904685379.97
712Prescriptions - paracetamol | antipyreticUKBB000006969.97
713Prescriptions - antipyreticUKBB000006659.97
714Lichen sclerosus et atrophicusFING000007239.93
715CD58/MEGF10 ratioGCST903138539.93
716Mean corpuscular volumeGCST900023929.89
717PRG2 levelsGCST904703229.87
718TNF/TNFRSF1B ratioGCST903159429.87
719Myasthenia gravisGCST904321569.87
720Dermatomycosis (PheCode 110.2)GCST904755659.86
721Other intervertebral disc disordersFING000010639.86
722IBD (strict) with PSCFING000006579.78
723LAT/PLXNA4 ratioGCST903152869.78
724DNMBP/WWP2 ratioGCST903145229.78
725CDKN2D/FOXO1 ratioGCST903139859.77
726TXNDC15 levelsGCST904709909.74
727Principal component-derived dietary pattern 21GCST901330269.73
728aparc-Desikan lh area fusiformGCST900030799.73
729Mean corpuscular hemoglobinGCST0046309.70
730Crohns diseaseGCST904681219.70
731Bread type - Wholemeal or wholegrain | DietUKBB000001079.66
732IL22 levelsGCST904695829.65
733Acute upper respiratory infections of multiple and unspecified sitesFING000000359.61
734BAG6/BMP6 ratioGCST903134509.59
735N-acetylmethionine levelsGCST902002899.56
736SNX15 levelsGCST904706999.54
737NELL2/SEZ6L ratioGCST903155369.54
738Lung cancerGCST0047489.53
739TTN levelsGCST904709849.53
740DTI TBSS MD External capsule LGCST903846059.48
741VSTM2B levelsGCST904710569.48
742F2R/TNFRSF14 ratioGCST903147399.47
743CEACAM8/PGLYRP1 ratioGCST903140039.46
744IDP T1 FAST ROIs R front operc cortexGCST900025329.45
745Other haemoglobinopathiesFING000010539.44
746Left-hemisphere dorsal attention network to putamen white-matter structural connectivityGCST903027039.44
747Pollen allergyFING000011769.44
748Mean corpuscular volume (UKB data field 30040)GCST904680869.41
749DTI TBSS MD Superior longitudinal fasciculus RGCST903846129.40
750ITGB2 levelsGCST904696449.40
751Rheumatoid arthritis and other inflammatory (PheCode 714)GCST904762289.39
752RAPGEF2 levelsGCST904704269.39
753DXO levelsGCST904690559.37
754GSTA4 levelsGCST902412839.36
755DTI TBSS L1 Cingulum cingulate gyrus LGCST903844639.35
756Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)FING000001439.35
757GMPR2 levelsGCST904693679.33
758IDP dMRI TBSS ICVF Medial lemniscus RGCST900043359.32
759aseg lh volume Accumbens-areaGCST900026269.32
760HEXIM1/TRIAP1 ratioGCST903150549.32
761Erythematous conditions (PheCode 695)GCST904761779.31
762ERBIN/LYN ratioGCST903146949.29
763Primary sclerosing cholangitisGCST0040309.29
764Myo-inositol levelsGCST902435279.29
765Percentage of fucosylation of monogalactosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP82)GCST906685269.27
766Mean corpuscular haemoglobin (UKB data field 30050)GCST904680849.25
767DBNL/EDAR ratioGCST903144169.24
768CCL5/TACC3 ratioGCST903137079.24
769PXN levelsGCST904703969.22
770ATP5IF1/LYN ratioGCST903133899.22
771Atopic dermatitisGCST900185649.20
772Other systemic involvement of connective tissue (FG)FING000011169.20
773CD69/EDAR ratioGCST903138759.18
774TOR1AIP1 levelsGCST904709359.18
775Dried fruit consumptionGCST901329809.18
776Actinic keratosisFING000000139.17
777Completion of the aide-memoireGCST900127939.14
778Vertiginous syndromes and other disorders of vestibular system (PheCode 386)GCST904759059.14
779Congenital malformations of ovaries, fallopian tubes and broad ligamentsFING000003379.14
780LBR levelsGCST904697449.12
781Telomere length (principal component 1)GCST904351449.10
782DTI TBSS MD Superior corona radiata RGCST903845969.09
783EDAR/LAT2 ratioGCST903145829.09
784DNAJA2/PLXNA4 ratioGCST903145049.09
785KLRD1/LY9 ratioGCST903152619.06
786DTI TBSS MD Anterior limb of internal capsule LGCST903845899.06
787Other contact dermatitisFING000009909.03
788Other noninfective gastroenteritis and colitisFING000010779.03
789ARG1 levelsGCST904683509.00
790Triacylglycerol_56:6_[M+NH4]1+ levelsGCST900605538.98
791ITGB1BP2/TIA1 ratioGCST903152228.98
792CD72 levelsGCST904686468.98
793Mood swings | Mental healthUKBB000004828.95
794Basal cell carcinoma, excluding all cancers (controls excluding all cancers)FING000001428.95
795neutrophil (fraction, maximum, inv-norm transformed)GCST904755358.94
796Blood cell traits latent factor 23 (white cell)GCST905592658.94
797Phenylacetate levelsGCST901996308.94
798Spondylopathies (FG)FING000013268.93
799Fibroblastic disordersFING000005428.92
800CD163/ICAM1 ratioGCST903137358.90
801Fluid intelligence score decline (log-difference score)GCST905658528.89
802Ankylosing spondylitisFING000000898.89
803B2M levelsGCST904684098.87
804IDP T1 FIRST left hippocampus volumeGCST900024448.87
805Overweight, obesity and other hyperalimentation (PheCode 278)GCST904757598.86
806Hair colour (natural, before greying): Light brown (UKB data field 1747_3)GCST900418388.82
807CXCL9 levelsGCST902747848.80
808Ulcerative colitisGCST904681528.78
809Type 1 diabetesGCST900187058.77
810GPI levelsGCST904693918.76
811CASP8/PPP3R1 ratioGCST903136548.74
812FCRL5/TNFRSF13B ratioGCST903148058.74
813N2-acetyl,N6,N6-dimethyllysine levelsGCST902006978.72
814Parental longevity (combined parental age at death)GCST0067028.72
815NRSN1 levelsGCST902420628.71
816Destinations on discharge from hospital (recoded) - Usual Place of residence | Summary AdministrationUKBB000001678.69
817Hair colour (natural, before greying): Black (UKB data field 1747_5)GCST900418408.67
818Bread type: Wholemeal or wholegrain (UKB data field 1448_3)GCST901329668.66
819CD20 on IgD- CD38- B cellGCST900017558.64
820Asthma, unspecified (mode)FING000001208.62
821SEMA4D levelsGCST904705738.61
822GP1BA/HBEGF ratioGCST903149568.59
823Mean corpuscular volumeGCST0046028.56
824Aplastic anemia (PheCode 284)GCST904757838.53
825PLXNA4/SRPK2 ratioGCST903156888.51
826CCL8 levelsGCST904223468.50
827LY96 levelsGCST904698238.49
828Mean corpuscular haemoglobin | Blood countUKBB000004478.49
829Taking other prescription medications | MedicationUKBB000008138.48
830Bifidobacterium catenulatum abundance in stoolGCST900322248.48
831DTI autoptx L3 ifo l tractGCST903852058.48
832DGKA levelsGCST904689898.48
833Red blood cell countGCST900187518.47
834Poultry consumptionGCST901329968.47
835IDP dMRI TBSS OD Posterior limb of internal capsule RGCST900044208.45
836Ectopic pregnancyFING000004878.43
837DTI autoptx L3 str r tractGCST903852178.42
838SNAP29/VEGFC ratioGCST903158628.42
839CRACR2A/IRAG2 ratioGCST903142278.41
840DTI autoptx L2 slf l tractGCST903851878.40
841Never eat sugar vs no sugar restrictions (UKB data field 6144)GCST901329348.38
842CA5A/GSTA1 ratioGCST903135918.37
843ITGB7 levelsGCST904696478.36
844Autoimmune hepatitisGCST900185658.36
845Seminoma of testis, excluding all cancers (controls excluding all cancers)FING000012898.35
846IDP dMRI TBSS L1 Posterior limb of internal capsule RGCST900040938.34
847DTI autoptx L1 slf r tractGCST903851618.34
848Hepatic cancerGCST900186388.33
849Late-onset myasthenia gravisGCST900934668.32
850EDIL3 levelsGCST904690728.32
851DTI TBSS L2 Genu of corpus callosumGCST903844788.30
852APRT/MIF ratioGCST903133368.29
853Acute sinusitisFING000000318.29
854ICAM3/SLAMF7 ratioGCST903151238.28
855CXCL5/MESD ratioGCST903143508.27
856Pre-existing hypertension complicating pregnancy, childbirth and the puerperiumFING000012038.26
857TNFRSF13B/TNFRSF9 ratioGCST903159328.23
858FOXO3/SH2B3 ratioGCST903148818.21
859Nasal polypsGCST904681438.21
860CD84/F2R ratioGCST903139128.18
861PARK7 levelsGCST904701598.18
862Sources of admission to hospital (recoded) - Usual Place of residence | Summary AdministrationUKBB000007868.18
863TNFRSF9 levelsGCST904709168.16
864Volume of right paralaminar nucleusGCST904750518.15
865DTI TBSS L2 Posterior thalamic radiation RGCST903845048.13
866RAP1A levelsGCST904704258.10
867Never eat wheat vs no wheat restrictions (UKB data field 6144)GCST901329328.10
868ENO2/PLXNA4 ratioGCST903146658.10
869Other dorsopathies, not elsewhere classifiedFING000010418.08
870Mean corpuscular volume | Blood countUKBB000004498.06
871TNFSF14 levelsGCST904709228.06
872Methods of admission to hospital (recoded) - Elective admission: Planned | Summary AdministrationUKBB000004628.06
873Hair colour (natural, before greying) - Light brown | Sun exposureUKBB000002988.05
874Other obstetric traumaFING000010828.05
875Peripheral enthesopathies and allied syndromes | musculoskeletalUKBB000006408.03
876CDSN/LY6D ratioGCST903139978.03
877RCC1 levelsGCST904704438.02
878CD83/IL12A_IL12B ratioGCST903139058.00
879EPHB6/TNFRSF9 ratioGCST903146827.99
880TP53BP1 levelsGCST904709367.98
881Prescriptions - albuterol | beta2-agonist,bronchodilator,asthmaUKBB000006587.97
882Prescriptions - beta2-agonist|bronchodilator|asthmaUKBB000006707.97
883CDKN2D/TACC3 ratioGCST903139927.97
884DTI autoptx MD slf r tractGCST903852427.93
885PTP4A3 levelsGCST904703757.88
886Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)FING000010677.87
887Operation code - hysterectomy | OperationsUKBB000005597.87
888SPESP1 levelsGCST904707207.85
889T1 FreeSurfer a2009s lh S central thicknessGCST903847867.84
890GFRA2/IL12A_IL12B ratioGCST903149257.84
891DNAJC9 levelsGCST904690187.82
892GBP4 levelsGCST904693137.80
893CXCL5/PLXNA4 ratioGCST903143517.78
894Strenuous sports or other exercisesGCST0061007.78
895DTI TBSS L3 Posterior thalamic radiation LGCST903845537.77
896DTI TBSS MD Anterior corona radiata LGCST903845957.77
897SOD1 levelsGCST904707047.77
898BCL2L15 levelsGCST904684317.75
899Type 1 diabetes with ophthalmic manifestations (PheCode 250.13)GCST904756637.74
900Cancer of bronchus; lung (PheCode 165.1)GCST904755737.73
901BCR/ITGB1BP2 ratioGCST903134947.71
902CNTNAP4 levelsGCST904688097.69
903CXCL16 levelsGCST900120597.68
904QDPR levelsGCST904704007.68
905Non-cancer illness year/age first occurred | Medical conditionsUKBB000005237.67
906VNN2 levelsGCST904710447.67
907FCRL2/LY9 ratioGCST903147997.66
908Neutrophil percentage of white cellsGCST0046337.64
909NPDC1/PTGDS ratioGCST903155497.62
910APP/BIN2 ratioGCST903133167.62
911CRYBB1 levelsGCST904688747.61
912ESAM/FUT8 ratioGCST903147117.61
913SLAMF8 levelsGCST904706527.60
914HippSubfield lh volume Whole-hippocampal-headGCST900026887.59
915KYNU/SCLY ratioGCST903152657.59
916SERPINE1/USP8 ratioGCST903158357.58
917General happiness | Happiness and subjective well-beingUKBB000002807.57
918Athlete's foot (PheCode 110.12)GCST904755637.57
919TNFRSF14/TNFSF14 ratioGCST903159367.54
920SUOX levelsGCST904707857.54
921CASP10 levelsGCST904685427.52
922Polymyalgia rheumaticaFING000011887.49
923HNRNPUL1 levelsGCST904694707.49
924EFNA4/TNFRSF9 ratioGCST903146067.48
925Triacylglycerol_52:4_[M+NH4]1+ levelsGCST900605087.48
926CALCOCO1/IRAG2 ratioGCST903136047.48
927TNFSF13B levelsGCST904709207.47
928TOP2B levelsGCST904709347.46
929DLG4 levelsGCST904690017.45
930FKBP4 levelsGCST904692437.45
931DTI TBSS L3 Superior longitudinal fasciculus RGCST903845647.44
932Suppurative and unspecified otitis mediaFING000013467.44
933X-16087 levelsGCST902005377.43
934FUT8/VEGFC ratioGCST903148967.43
935KHK levelsGCST904696757.42
936White blood cell countGCST900024077.42
937AHCY/HSPA1A ratioGCST903132117.42
938APP/HBEGF ratioGCST903133247.38
939FCRL1/TCL1A ratioGCST903147957.37
940Treatment or medication use - insulin product (UKB data field 20003_1140883066)GCST900422267.37
941Chronic diseases of tonsils and adenoidsFING000002837.37
942ADH4/CA5A ratioGCST903131897.36
943Polyp of the female genital tractFING000011907.36
944APRT/EREG ratioGCST903133357.36
945CASP10/ING1 ratioGCST903136257.36
946PLXNA4/SUSD1 ratioGCST903156897.35
947FCER2/TNFRSF9 ratioGCST903147917.34
948CCL5/SELP ratioGCST903137057.34
949Chronic pancreatitisGCST900186017.33
950Phosphatidylcholine acyl-alkyl C36:4 levelsGCST902400727.33
951DAPP1/ITGB1BP2 ratioGCST903143887.32
952Right-hemisphere visual network to right-hemisphere dorsal attention network white-matter structural connectivityGCST903027767.32
953Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)FING000008467.31
954APRT/PSME1 ratioGCST903133387.31
955Never eat eggs, dairy, wheat, sugar - Sugar or foods/drinks containing sugar | DietUKBB000005017.29
956NT5C levelsGCST904700927.29
957EDAR/SNAP23 ratioGCST903145877.25
958Symptoms concerning nutrition, metabolism, and development (PheCode 1002)GCST904755567.25
959PPP1R14D levelsGCST904703037.24
960PPP1R12A/VEGFC ratioGCST903157157.24
961XCL1 levelsGCST904710817.23
962ThalamNuclei rh volume MGNGCST900027377.22
963VCAM1 levelsGCST904710317.22
964Tea difference likingGCST900948557.21
965CD27/TNFRSF13B ratioGCST903137777.21
966MPHOSPH8/USP8 ratioGCST903154797.20
967Principal component-derived dietary pattern 16GCST901330217.20
968White blood cell countGCST900023747.20
969Volume of right central nucleusGCST904750277.19
970KLRB1/KLRD1 ratioGCST903152607.19
971Non-allergic asthma (mode) (more control exclusions)FING000008697.18
972CCL13/CCL17 ratioGCST903136747.17
973TNFSF12/TNFSF13 ratioGCST903159417.16
974IDP dMRI TBSS FA Posterior limb of internal capsule RGCST900038957.14
975Volume of right accessory basal nucleusGCST904750097.13
976CD86 levelsGCST904686547.10
977Cervical disc disordersFING000002657.09
978APEX1 levelsGCST904683297.09
979FOLR2/HAVCR2 ratioGCST903148657.09
980Plasma homoarginine levels in chronic kidney diseaseGCST902653457.08
981CCL3 levelsGCST904685827.08
982DAB2/FKBP1B ratioGCST903143627.08
983FYN levelsGCST902432007.07
984PTPRS levelsGCST904703877.07
985Never eat wheat vs no eggs, dairy, wheat or sugar restrictions (UKB data field 6144)GCST901329317.07
986Interpolated Age of participant when non-cancer illness first diagnosed | Medical conditionsUKBB000003697.05
987Ever taken cannabis | Cannabis useUKBB000002247.03
988CD46/TIMP1 ratioGCST903138377.02
989GGACT levelsGCST904693337.01
990HTRA2/SIAE ratioGCST903150977.01
991Viral haemorrhagic fevers, not elsewhere classified/unspecifiedFING000014337.01
992SNAP23/TXLNA ratioGCST903158577.01
993CANT1/GSTA1 ratioGCST903136167.00
994red blood cell count (RBC, mean, inv-norm transformed)GCST904763477.00
995Cancer of urinary organs (incl. kidney and bladder) (PheCode 189)GCST904755937.00
996Intrinsic epigenetic age accelerationGCST900142906.99
997wg lh intensity-contrast rostralmiddlefrontalGCST900038186.99
998Crohn's disease of large intestineFING000003686.98
999CLEC1B/HBEGF ratioGCST903140926.98
1000Ceramide (d18:2/24:1) levelsGCST900246846.98